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Abstract
Herpes simplex virus type 1 (HSV-1) UL37 is a 1,123 amino acid tegument protein that self-
associates and binds to the tegument protein UL36 (VP1/2). Studies were undertaken to identify
regions of UL37 involved in these protein-protein interactions. Coimmunoprecipitation assays
showed that residues within the carboxy-terminal half of UL37, amino acids 568–1123, are
important for interaction with UL36. Coimmunoprecipitation assays also revealed that amino
acids 1–300 and 568–1123 of UL37 are capable of self-association. UL37 appears to self-associate
only under conditions when UL36 is not present or is present in low amounts, suggesting UL36
and UL37 may compete for binding. Transfection-infection experiments were performed to
identify domains of UL37 that complement the UL37 deletion virus, KΔUL37. The carboxy
terminal region of UL37 (residues 568–1123) partially rescues the KΔUL37 infection. These
results suggest the C-terminus of UL37 may contribute to its essential functional role within the
virus-infected cell.
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INTRODUCTION
Herpesvirus virions are composed of three morphologically distinct structures: the capsid,
the tegument and the envelope (reviewed in Roizman et al., 2007). The 150 kbp linear DNA
genome is enclosed within the icosahedral capsid. The virion is bounded by a host-derived
lipid envelope that contains approximately 12 virus-encoded glycoproteins (reviewed in
Roizman et al., 2007). The proteinaceous region between the capsid and envelope is termed
the tegument. Approximately 25 virus-encoded proteins, as well as trace amounts of host
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proteins, make up the tegument region (reviewed in Kelly et al., 2009; Mettenleiter et al.,
2009).
During herpesvirus replication, the viral genome is packaged into assembled capsids within
the nucleus of the infected cell. The capsid acquires an envelope by budding into the inner
nuclear membrane and enters the perinuclear space. The capsid loses its primary envelope as
it subsequently fuses with the outer nuclear membrane and the capsid is released into the
cytoplasm (reviewed in Mettenleiter et al., 2009). It has also been reported that capsids may
escape the nucleus by exiting through damaged nuclear pores (Leuzinger et al., 2005; Wild
et al., 2005). Detectable quantities of HSV-1 tegument proteins UL36 (VP1/2) and UL37
(Bucks et al., 2007), as well as vhs (Read & Patterson, 2007), have been reported on capsids
isolated from the nucleus. However, other groups failed to detect HSV-1 UL36 and UL37
associated with detergent-treated capsids isolated from the nucleus of infected cells
(Newcomb & Brown, 2010, Radtke et al., 2010, Trus et al., 2007, Wolfstein et al., 2006).
Other tegument proteins including HSV-1 VP16, HSV-1 VP22 and HSV and pseudorabies
virus (PRV) US3 proteins have been shown to associate with capsids within the perinuclear
space (Granzow et al., 2004; Naldinho-Souto et al., 2006; Padula et al., 2009; Reynolds et
al., 2002) suggesting the earliest events in tegumentation occur within these sites. After
exiting the nucleus the cytoplasmic capsids travel through the secretory pathway. It has been
suggested that some tegument proteins, such as HSV-1 UL16, interact with the capsid as it
travels in the cytoplasm on its journey toward the trans-Golgi network (TGN) (Meckes, Jr.
& Wills, 2007). The capsid obtains a lipid envelope by budding into vesicles derived from
the TGN. Many, if not all, tegument proteins are associated with TGN-derived vesicles
through membrane binding domains or through interactions with membrane bound
glycoproteins and/or membrane bound tegument proteins. The TGN-membrane-associated
tegument proteins and glycoproteins are incorporated into the virion during final
envelopment (Mettenleiter et al., 2009).
The morphogenesis and structure of the tegument appear to be complex, with many details
only recently being uncovered. With the exception of the innermost layers, the tegument
region is described as asymmetrical in nature (Grunewald et al., 2003; Zhou et al., 1999).
Recent evidence suggests the tegument region may not be a static structure, but instead may
undergo a time-dependent maturation process after release of the virion from the infected
cell (Newcomb & Brown, 2009). The maturation of the virion results in changes in tegument
structure including loss of protein symmetry surrounding the capsid and increased resistance
to detergent extraction (Newcomb & Brown, 2009). There is also evidence that structural
changes in the tegument occur upon binding of the virion to the host cellular receptor
heparan (Meckes, Jr. & Wills, 2008). Virion binding to the heparan receptor causes the
disassociation of at least one tegument protein, UL16, from the capsid (Meckes, Jr. & Wills,
2008).
A myriad of protein-protein interactions among tegument proteins has been described, and
these interactions likely play important roles in facilitating the incorporation of tegument
proteins into the assembling virion. Two proteins of interest in this study are tegument
proteins encoded by the UL36 and UL37 genes. UL36, also known as VP1/2, binds UL37
(Klupp et al., 2002). UL36 is the largest known herpesvirus-encoded protein and the HSV-1-
encoded UL36 protein is approximately 270 kDa (Heine et al., 1974; Honess & Roizman,
1973; Spear & Roizman, 1972). HSV-1 UL36 interacts with capsid proteins VP5 and UL25
(Coller et al., 2007; McNabb & Courtney, 1992; Pasdeloup et al., 2009), and is bound tightly
to the capsid (Gibson & Roizman, 1972; Spear & Roizman, 1972). UL36, and its
homologues in all herpesvirus subfamilies, functions as a deubiquitinating enzyme
(Kattenhorn et al., 2005; Schlieker et al., 2005). The conserved UL36 tegument protein is
important for productive infection, playing roles at early times, as well as late times during
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infection. During translocation of incoming capsids to the nucleus, UL36 associated with the
incoming HSV-1 capsid is cleaved, resulting in changes to the capsid that allow the viral
genome to be released into the nucleus (Jovasevic et al., 2008). Studies of HSV-1 and PRV
UL36 deletion viruses indicate that in the absence of UL36, DNA filled capsids accumulate
in the cytoplasm, are not associated with appreciable amounts of tegument and do not
undergo secondary envelopment (Desai, 2000; Fuchs et al., 2004; Luxton et al., 2006;
Roberts et al., 2009). Furthermore, Luxton and colleagues reported that a PRV UL36
deletion virus showed reduced microtubule-based transport of capsids in the cytoplasm
(Luxton et al., 2006).
UL37 encodes a conserved 120 kDa phosphorylated tegument protein (Albright & Jenkins,
1993; McLauchlan et al., 1994; Schmitz et al., 1995; Shelton et al., 1990). UL37 is
distributed throughout the cell and contains a nuclear export signal (McLauchlan et al.,
1994; McLauchlan, 1997; Schmitz et al., 1995; Watanabe et al., 2000). HSV-1 UL37
functions to activate NF-κB signaling by binding TRAF6 (Liu et al., 2008). The amount of
HSV-1 UL37 packaged into the virion is tightly controlled, as increasing expression of the
protein does not increase the abundance of UL37 in virions (McLauchlan, 1997).
During virus assembly UL37 may have a function in the cytoplasm as well as the nucleus. In
cells infected with a mutant virus containing a deletion of HSV-1 UL37, KΔUL37, DNA-
filled capsids accumulate in the nucleus (Desai et al., 2001); however, in cells infected with
another HSV-1 UL37 deletion virus, ΔUL37[86–1035], an accumulation of nuclear capsids
was not observed (Leege et al., 2009). Roberts and colleagues constructed a third HSV-1
UL37 deletion virus, FRΔUL37. Infection with FRΔUL37 did not result in an accumulation
of capsids in the nucleus but yielded an accumulation of large aggregates of cytoplasmic
capsids, similar to capsid aggregates also observed in KΔUL37-infected cells (Desai et al.,
2001; Roberts et al., 2009). None of the HSV-1 UL37 deletion viruses yield productive
infections (Desai et al., 2001; Leege et al., 2009; Roberts et al., 2009). PRV UL37 deletion
viruses produced titers approximately 100–1,000-fold lower than wild type and showed no
accumulation of capsids within the nucleus (Klupp et al., 2001; Luxton et al., 2006).
Secondary envelopment is inhibited in HSV-1 and PRV UL37 deletion viruses, resulting in
an accumulation of capsids in the cytoplasm (Desai et al., 2001; Klupp et al., 2001; Leege et
al., 2009; Luxton et al., 2006; Roberts et al., 2009).
Coimmunoprecipitation and yeast two-hybrid interaction studies have revealed that HSV-1
UL37 may interact with several other viral proteins. In a yeast two-hybrid analysis, HSV-1
UL37 interacts with the capsid proteins VP26 and VP19c (Lee et al., 2008). UL37 also
participates in interactions with other tegument proteins, including UL46 and UL36 (Fossum
et al., 2009; Klupp et al., 2002; Lee et al., 2008; Uetz et al., 2006; Vittone et al., 2005).
Furthermore, HSV-1 UL37 interacts with itself, as indicated by yeast two-hybrid analysis
and coimmunoprecipitation studies (Lee et al., 2008; Vittone et al., 2005).
Based on its tight association with the capsid, it has been suggested that UL36 may be one
of the first tegument proteins to associate with the capsid, and may act as a foundation to
bind other tegument proteins to the capsid (Mettenleiter et al., 2009). Studies revealing the
association of HSV-1 UL36 and UL37 with capsids isolated from the nuclear fraction also
support this hypothesis (Bucks et al., 2007). The interaction of UL36 with the capsid may
aid or enhance the incorporation of UL36 binding partners, such as UL37 or VP16 (Ko et
al., 2010, Lee et al., 2008; Mettenleiter et al., 2009; Vittone et al., 2005). UL36 and UL37
physically interact, but the functional importance of the interaction is perhaps only
beginning to be understood (Klupp et al., 2002). Desai and colleagues reported that the
localization of HSV-1 UL37 in the Golgi complex is dependent on UL36 (Desai et al.,
2008). Furthermore, based upon the work of Roberts and colleagues, HSV-1 UL36 and
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UL37 appear to rely on one another for incorporation into L particles (Roberts et al., 2009).
Interestingly, the incorporation of UL37 and UL36 into L particles may be dependent on
VP16, as L particles produced from a PRV VP16 deletion mutant, PRV-ΔUL48, do not
contain these proteins (Fuchs et al., 2002). Consistent with this finding, HSV-1 UL36 has
been reported to interact with VP16 in yeast two-hybrid and pulldown assays (Ko et al.,
2010, Lee et al., 2008; Vittone et al., 2005).
Vittone and colleagues have determined that the region containing amino acids 512–767 of
HSV-1 UL36 is necessary for binding UL37 (Vittone et al., 2005). Mijatov and colleagues
extended these studies to identify residues F593 and E596 of HSV-1 UL36 as essential for
the interaction (Mijatov et al., 2007). Furthermore, Fuchs and colleagues have reported that
deletion of the UL37 binding domain of UL36 does not abolish PRV replication, suggesting
that the essential function(s) of UL36 is not dependent on binding UL37 (Fuchs et al., 2004).
The region of UL37 that participates in its interaction with UL36 as well as the region(s) of
UL37 that participates in self-association have not been identified and are the focus of our
report. These studies are important for several reasons. First, the interaction of UL36 and
UL37 is conserved among the alpha-, beta-, and gammaherpesviruses (Bechtel & Shenk,
2002; Klupp et al., 2002; Lee et al., 2008; Rozen et al., 2008; Uetz et al., 2006; Vittone et
al., 2005). Furthermore, UL36 plays an essential role in the assembly of HSV-1 and PRV
(Desai, 2000; Fuchs et al., 2004; Luxton et al., 2006; Roberts et al., 2009). In addition, UL37
plays an essential role for assembly of HSV-1 and varicella zoster virus (VZV) and a critical
role in the assembly of PRV (Desai et al., 2001; Klupp et al., 2001; Luxton et al., 2006;
Pasdeloup et al., 2010, Roberts et al., 2009; Xia et al., 2003). A greater understanding of the
interaction between UL36 and UL37 will help elucidate the role(s) that the UL36–UL37
interaction plays during assembly of herpesvirus virions. We have identified a region within
the carboxy-terminal half of HSV-1 UL37 to be necessary for binding to UL36.
Furthermore, we have determined that both carboxy and amino-terminal regions of UL37
are capable of self-association, and can interact with one another. In a trans-
complementation assay, when plasmids encoding UL37 truncation mutants were transfected
into cells followed by infection with a UL37 deletion virus, a mutant protein encompassing
the carboxy-terminal half of UL37 was found to complement the infection with the UL37
deletion virus.
RESULTS
Identification of the region of UL37 involved in binding UL36
A series of hemagglutinin (HA) tagged UL37 truncation mutants was constructed and used
in coimmunoprecipitation assays to identify the region of UL37 involved in binding UL36
(Fig. 1A). UL37 truncation mutants were designed to avoid major disruptions in secondary
structure that may result from protein truncations in the middle of hydrophobic regions. A
GFP expressing plasmid encoding the region of UL36 necessary for binding UL37, amino
acids 512–767, was generated (UL36.512-767GFP). N-terminal and C-terminal truncation
mutants of UL37, containing a hemagglutinin (HA) tag at the carboxy-terminus, were
cotransfected into Vero cells with UL36.512-767GFP. Cells were lysed in NP40 lysis buffer
and the nuclear fraction was discarded. The detergent lysis buffer presumably solubilizes
cytoplasmic membranes, resulting in the disruption of cytoplasmic compartments and
release of all cytoplasmic proteins to potentially interact in coimmunoprecipitation
experiments. Anti-HA antiserum was used to immunoprecipitate the UL37HA mutant
proteins. Immune complexes were captured by incubating the lysates with Protein G-agarose
beads. SDS-PAGE and Western blotting were performed to verify expression of the
cotransfected plasmids (Fig. 1B) and identify the UL37HA mutants capable of
coimmunoprecipitating UL36.512-767GFP (Fig. 1C). As expected, full-length UL37HA
coimmunoprecipitated UL36.512-767GFP. UL37 mutants encoding amino acids 1–300 or
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1–567 of UL37 did not coimmunoprecipitate UL36. Extension of the amino-terminal
mutants to include residues 1–809 restored binding to UL36. Furthermore, mutants
UL37.568-1123HA and UL37.301-1123HA were also capable of binding
UL36.512-767.GFP. These results suggest that residues 568–809 of UL37 are important for
interaction with UL36.
To further address the role that amino acids 568–809 of UL37 play in the interaction with
UL36, a UL37 mutant containing an internal deletion of these amino acids,
UL37.Δ568-809HA, was constructed (Fig. 2A). Vero cells were cotransfected with
UL37HA constructs and UL36.512-767GFP, subsequently lysed for coimmunoprecipitation
with anti-HA antiserum, and protein interactions visualized by SDS-PAGE and Western
blotting. Expression of the transfected plasmids in cell lysates is shown in Fig. 2B.
Immunoprecipitated material is presented in Fig. 2C. As also seen in Figure 1, truncation
mutants UL37.1-809HA, UL37.568-1123HA and UL37.301-1123HA coimmunoprecipitated
UL36.512-767GFP. When analyzed in coimmunoprecipitation assays, deletion of amino
acids 568–809 within full-length UL37 decreased binding to UL36 to nearly background
levels (Fig. 2C). This result suggests that amino acids 568–809 of UL37 are functionally
important for the interaction of UL36 and UL37, or alternatively this region plays an integral
role in the structure of UL37 that is necessary for its interaction with UL36.
Results shown in Figures 1 and 2 suggest that amino acids 568–809 of UL37 are necessary
for the interaction with UL36. Experiments were performed to determine if these amino
acids are sufficient to enable UL36 binding. HA tagged UL37 truncation mutants containing
amino acids 568–809, or amino acids extending outward from that region were generated
(Fig. 3A). Plasmids encoding the UL37HA truncation mutants and UL36.512-767GFP were
cotransfected into cells and analyzed by coimmunoprecipitation and Western blotting.
Several of the internal UL37 mutants reproducibly exhibited relatively low protein
expression as compared to the full length protein (Fig. 3B). When the internal UL37 mutants
were immunoprecipitated with anti-HA antisera, Western blotting with anti-GFP antisera
revealed that UL36.512-767GFP failed to coimmunoprecipitate with any of the internal
UL37HA mutant proteins (Fig. 3C). These results suggest that although amino acids 568–
809 of UL37 are necessary for interaction with UL36, they are not sufficient for this
interaction. The failure of the UL37HA truncation mutants to bind UL36 may suggest that
amino acids outside the region of 568–809 are involved in binding to UL36 and/or
maintaining the proper conformation of UL37 necessary for its interaction with UL36.
As shown in Figures 1 and 2, the C-terminal half of UL37, containing residues 568–1123, is
sufficient for binding UL36.512-767GFP. In an effort to define a smaller region of UL37
that is sufficient for UL36 binding, additional HA tagged plasmids encoding internal regions
of UL37 were constructed (Fig. 4A). UL37HA truncation mutants and UL36.512-767GFP
were cotransfected into cells to be used in coimmunoprecipitation assays. Protein expression
(Fig. 4B) and protein interactions (Fig. 4C) were visualized by SDS-PAGE and Western
blotting. The internal UL37HA truncation mutants reproducibly displayed multiple protein
bands, suggestive of protein degradation. The GFP Western blot of cell lysates (Fig. 4B,
bottom panel) depicts multiple protein bands in the UL37.489-1021 sample due to
incomplete stripping of anti-HA antibody from the membrane before the GFP Western blot
was performed. Coimmunoprecipitation with anti-HA antibody showed that UL37
truncation mutants encoding amino acids 391–1021 or 743–1123 do not reproducibly bind
UL36.512-767GFP above background levels. However, UL37 truncation mutants containing
amino acids 489–1021, 568–1021, or 624–1123 coimmunoprecipitated UL36.512-767GFP;
although binding is markedly lower than binding with full length UL37. The smallest
truncation mutant of UL37 that facilitates an interaction with UL36 is UL37.568-1021HA.
Together, these results suggest that amino acids 624–1021 would also be sufficient for
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interaction with UL36. To address this issue a UL37 truncation mutant expressing amino
acids 624–1021 was constructed and analyzed in coimmunoprecipitation assays as described
above. Surprisingly, UL37.624-1021HA was not able to interact with UL36, although
protein expression was considerably less than full length UL37 (data not shown).
Collectively, these coimmunoprecipitation studies indicate that residues 568–809 of UL37
are necessary for interaction with UL36. Amino acids 568–809 may directly interact with
UL36 or, alternatively, deletion of this region may cause major disruptions in the protein
structure, thus inhibiting the interaction with UL36. The carboxy-terminal half of UL37 is
sufficient for interaction with UL36, but further truncation of this region results in little, if
any, binding to UL36. These results suggest that UL37 may be conformationally-sensitive to
truncations within the carboxy-terminus.
Identification of domains involved in self-association of UL37
UL37 has been shown by yeast two-hybrid and coimmunoprecipitation assays to self
associate (Lee et al., 2008; Vittone et al., 2005). To ascertain the region(s) of UL37 involved
in self-association of the protein, GFP-tagged UL37 truncation mutants were generated (Fig.
5A). A plasmid encoding full length UL37HA was cotransfected into cells with plasmids
encoding UL37GFP truncation mutants. Protein interactions were assayed by
coimmunoprecipitation with anti-GFP antisera. Western blotting with rabbit antibodies to
GFP and HA were used to verify protein expression (Fig. 5B). Anti-HA immunoblots show
that truncation mutants encoding either N-terminal or C-terminal regions of UL37 were
capable of interacting with full length UL37HA (Fig. 5C). UL37 truncation mutants
containing amino acids 1–809, 1–300, 301–1123 or 589–1123 were able to
coimmunoprecipitate full length UL37HA (Fig. 5C). A construct encoding amino acids 1–
567 repeatedly did not interact with UL37HA in binding assays; this is an intriguing
observation because a smaller truncation mutant encoding amino acids 1–300 does bind full
length UL37HA. This finding suggests that removal of the C-terminal half of UL37GFP
may cause the protein to misfold, thus blocking its ability to bind UL37HA. However,
further truncation of the UL37GFP mutant from the C-terminus, resulting in
UL37.1-300GFP, restores binding to UL37HA, possibly by exposing an amino-terminal
UL37 self-association domain that was presumably masked or misfolded in
UL37.1-567GFP.
UL37 appears to contain two domains involved in interaction with full length UL37,
residues 1–300 and 568–1123. Cells were cotransfected with HA and GFP tagged UL37
constructs and coimmunoprecipitation assays were used to determine if the amino and
carboxy-terminal interaction domains bind to one another and if the mutant UL37 domains
self interact (Fig. 6A). In UL37 binding assays, UL37.1-567GFP, which does not bind full
length UL37, was used as a negative control. Protein expression was assayed by Western
blotting cytoplasmic lysates with anti-HA (top panels) and anti-GFP (bottom panels)
antibodies (Figs. 6B, D and F). Immunoprecipitation with anti-GFP antisera and Western
blotting with anti-HA antibody revealed that UL37.1-300HA and UL37.568-1123GFP
interact in cotransfected cells (Fig. 6C). Binding assays also showed that UL37.1-300GFP is
capable of binding UL37.1-300HA and that UL37.568-1123GFP is capable of interacting
with UL37.568-1123HA (Figs. 6C and E, respectively). Fig. 6G shows that HA and GFP-
tagged truncation mutants containing amino acids 1–567 are not capable of self-association,
further suggesting that this mutant protein may lack proper structure that enables self-
interaction. These results suggest that UL37 contains two domains involved in self-
association of the protein. Mutants encoding either of the interaction domains are capable of
self-association with full length UL37 and the two interaction domains can be
coimmunoprecipitated in a complex. Furthermore, HA-tagged mutants encoding residues 1–
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300 or 568–1123 can self-interact with GFP-tagged mutants encoding residues 1–300 or
568–1123, respectively.
Results from UL36–UL37 binding assays indicated that amino acids 568–809 of UL37 are
necessary for the interaction with UL36 (Fig. 1 and 2). It is possible that deletion of amino
acids 568–809 of UL37 causes the protein to misfold, thus inhibiting protein-protein
interactions. To determine if an internal deletion of this region of UL37 negatively affects
self-association of UL37, we generated a UL37.Δ568-809GFP mutant to be used in
coimmunoprecipitation studies. Plasmids encoding UL37.Δ568-809GFP and UL37HA were
cotransfected into cells, lysed and analyzed by coimmunoprecipitation with anti-GFP
antisera. Immunoblots with anti-HA antisera indicate that residues 568–809 of UL37 are not
sufficient for self-association of UL37. UL37.Δ568-809GFP coimmunoprecipitated
UL37GFP, indicating that amino acids 568–809 of UL37 are not necessary for the self-
interaction (Fig. 7C). These results suggest that this region, amino acids 568–809, is integral
for the interaction with UL36 but not for self-association of UL37.
Do UL37 and UL36 compete for binding to UL37?
UL37 contains two self-association domains, amino acids 1–300 and 568–1123. The UL36
binding domain of UL37 overlaps the C-terminal UL37 self-association domain. In the
infected cell, UL37 and UL36 are present in the cytoplasm and nucleus at approximately the
same times. These observations raise the question whether UL36 and UL37 compete for
binding to UL37. Coimmunoprecipitation studies were used to determine if UL37 is capable
of binding UL37 and UL36 simultaneously or if one binding reaction inhibits the other.
Cells were cotransfected with UL37GFP, UL37HA and increasing amounts of
UL36.512-767GFP plasmids. Cells were lysed, proteins were coimmunoprecipitated with
anti-HA antisera and immune complexes were visualized by SDS-PAGE and Western
blotting. Western blotting of cytoplasmic lysates with anti-GFP antibody verified protein
expression of both GFP-expressing plasmids (Fig. 8A). Western blotting of the
immunoprecipitated material with anti-GFP antisera was used to determine if UL37GFP
and/or UL36.512-767GFP coimmunoprecipitated with UL37HA. When 0.5 ug of plasmid
encoding UL36.512-767GFP was cotransfected into cells with plasmids encoding UL37HA
and UL3 GFP, anti-GFP Western blots revealed that both UL37GFP and UL36.512-767GFP
coimmunoprecipitated with UL37HA (Fig. 8B). Thus, under relatively low levels of
expression of UL36.512-767GFP, UL37GFP bound UL37HA (Fig. 8B). However, as the
expression of UL36.512-767GFP protein increased, the amount of UL37GFP that
coimmunoprecipitated with UL37HA decreased. The self-interaction of UL37HA and
UL37GFP appeared to occur only when UL36.512-767GFP is not present in high quantities.
Similar results from seven independent experiments indicated that appreciable expression of
UL36.512-767GFP inhibits self-association of UL37HA and UL37GFP in
coimmunoprecipitation experiments. Furthermore, expression of UL37HA was increased by
transfecting greater amounts of DNA, but the increased expression of UL37HA failed to
restore UL37GFP interaction with UL37HA in the presence of UL36.512-767GFP (data not
shown). Based on these results it appears that UL37GFP and UL36.512-767GFP compete
for binding to UL37HA. This suggests that UL37HA does not bind UL37GFP and
UL36.512-767GFP simultaneously.
Identification of domains of UL37 that complement the UL37 deletion virus, KΔUL37
UL37 is necessary for assembly of HSV-1 virions; in the absence of UL37 proper
tegumentation and secondary envelopment do not occur (Desai et al., 2001; Roberts et al.,
2009). A trans-complementation assay was designed to determine the regions of UL37 that
rescue the replication deficient KΔUL37 virus to result in the production of infectious
virions. Cells were transfected with the indicated mutant UL37HA plasmids and 24 h later
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infected with KΔUL37. UL46HA was transfected as a negative control. At 48 h after
infection, cells and media were collected and subjected to three rounds of freeze/thaw,
cellular debris was pelleted and infectious virions were quantified by plaque assay on BD45
cells (Vero cells that stably express UL37). Western blotting of the transfected-infected cell
lysates was performed to verify expression of each of the transfected plasmids. All plasmids
used in this study contained the immediate early CMV promoter and produced robust
protein expression of all transfected plasmids in transfected-infected cells (data not shown).
The amounts of infectious virions released from cells transfected with UL37HA mutants
were determined and are represented as the percent of PFU/ml as compared to virions
released from cells transfected with full length UL37HA (Fig. 9). Plaque assays revealed
that a mutant protein encoding the C-terminal half of UL37, residues 568–1123, was capable
of rescuing the KΔUL37 virus to approximately 12% of the levels, or approximately one log
less than the amount released when a plasmid encoding full length UL37HA is transfected
(Fig. 9). The other tested UL37HA mutants yielded viral titers comparable to the UL46HA
control sample. These results indicate that the carboxy-terminal half of UL37 confers partial
complementation to the replication defective KΔUL37 virus. This result suggests that the
region of UL37, which is involved in binding UL36 and self-association, may play an
essential functional role during virus infection.
Does UL37.568-1123HA interact with UL36 in infected cells?
Results shown in figure 9 indicate that UL37.568-1123HA partially rescues the KΔUL37
virus. UL37.568-1123HA interacts with UL36.512-767GFP in cotransfected cells (Figs. 1
and 2). To determine if the ability of UL37.568-1123HA to rescue the KΔUL37 virus was
possibly due to its ability to interact with UL36, it was necessary to demonstrate that
UL37.568-1123HA interacts with virus-expressed full-length UL36. A
coimmunoprecipitation assay from transfected-infected cells was utilized to address this
question. To minimize the risk of coimmunoprecipitating UL37.568-1123HA and UL36
bound to a large capsid complex, transfected cells were infected with K23Z HSV-1 (Desai et
al., 1993), in which capsid formation is abrogated. Therefore, K23Z-infected cells allowed
the examination of the UL36 interaction with UL37.568-1123HA in the absence of capsid
formation. Cells were transfected with the indicated UL37HA plasmids and 24 h later
infected with K23Z HSV-1. Approximately 24 h after infection, cells were lysed, proteins
were coimmunoprecipitated with anti-HA antisera and immune complexes were visualized
by SDS-PAGE and Western blotting. Western blotting using anti-HA antiserum and anti-
UL36 antiserum verified expression of the transfected plasmids and viral UL36 respectively
(Fig. 10A). Immunoblots with anti-UL36 antiserum indicate that K23Z-expressed UL36
coimmunoprecipitated with full length UL37HA (Fig. 10B). As a negative control, cells
were transfected with UL37.1-567HA which does not interact with UL36.512-767GFP. As
expected, K23Z-expressed UL36 did not coimmunoprecipitate with UL37.1-567HA. In
contrast, K23Z-expressed UL36 coimmunoprecipitated with UL37.568-1123HA. These
results indicate that UL37.568-1123HA interacts with full-length UL36 in infected cells.
DISCUSSION
The studies described within this report were designed to identify domains of the UL37
tegument protein involved in its self-association, as well as its interaction with UL36. To our
knowledge, these are the first studies identifying domains of UL37 involved in these
interactions. These studies will help elucidate the role of the interaction between UL36 and
UL37 and the role that self-association of UL37 play during viral assembly. A schematic
summary of domains and epitopes of UL37 identified by this report and others is presented
in Figure 11.
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Several observations throughout these studies suggested that the conformation of UL37 may
be sensitive to mutations. First, UL37.1-567HA was the only truncation mutant that did not
interact with full length UL37. Although UL37.1-567HA contains the amino-terminal self-
association sequence (amino acids 1–300); UL37.1-567HA did not interact with either of the
self-association domains (regions 1–300 and 568–1123). These results suggest that due to
truncation, the structural conformation of UL37.1-567HA may be altered in such a way that
inhibits the self-interaction of UL37. Results from mapping the domain of UL37 involved in
UL36 binding also suggest that the conformation of UL37 is sensitive to truncations. The
carboxy-terminal half of UL37, encompassing amino acids 568–1123, is sufficient for
interaction with UL36. However, deletion of 102 amino acids from the unconserved C-
terminus of UL37 yields a truncation mutant, UL37.568-1021HA, that binds UL36 at low
levels. Furthermore, UL37.624-1123HA showed low levels of binding to UL36 (Fig. 4).
Collectively, these results suggested that a smaller construct encoding amino acids 624–
1021 would also bind UL36. However, when a plasmid encoding this region was
constructed and analyzed in coimmunoprecipitation assays, UL37.624-1021HA failed to
bind UL36 (data not shown), suggesting that amino acids surrounding this region within the
carboxy-terminus are important in maintaining the conformation of UL37 needed to bind
UL36. Interestingly, Luxton and colleagues reported that a GFP tag on the amino-terminus
of PRV UL37 was deleterious for viral growth, perhaps suggesting that GFP at this position
disrupts the conformation of UL37 (Luxton et al., 2005). Furthermore, Antinone and Smith
also reported that a GFP tag on the amino-terminus of HSV-1 UL37 decreased viral titers by
nearly one order of magnitude (Antinone & Smith, 2010).
The studies presented in this manuscript do not investigate the possibility that cellular and/or
viral proteins may bridge the interaction of UL36 and UL37. Previous studies, have reported
the HSV-1 UL36 and UL37 interaction, as well as HSV-1 UL37 self-association, in yeast
two-hybrid and coimmunoprecipitation studies in the absence of other viral proteins (Lee et
al., 2008, Vittone et al., 2005). Furthermore, coimmunoprecipitation results presented in this
manuscript demonstrate that additional viral proteins are not necessary to facilitate or bridge
the interaction of UL36 and UL37 minimal binding domains or UL37 self-association. The
possibility that cellular proteins bind UL36 and/or UL37 to facilitate the above interactions
cannot be dismissed entirely. Based upon the fact that the minimal binding domains of UL36
and UL37 interact in cotransfected cells, it seems unlikely that cellular factors are necessary
for the interaction of UL36 and UL37. In addition, relatively small self-association domains
of UL37 coimmunoprecipitate in transfected cells, also suggesting that cellular proteins are
not necessary for interaction. Although we suspect that cellular proteins are not necessary
for the UL36–UL37 interaction or UL37 self-association, it is possible that cellular and/or
viral proteins may enhance or facilitate these interactions in a variety of ways.
The UL37 domains involved in interaction with UL36, as well as its self-association, are
located in the carboxy-terminal region of UL37. We were curious if UL37 binds to
molecules of UL36 and UL37 at the same time, forming a complex. From cells
cotransfected with UL37HA, UL37GFP and UL36.512-767GFP, we observed that as the
amount of UL36.512-767GFP protein increased, the amount of UL37GFP that
coimmunoprecipitated with UL37HA decreased (Fig. 8). Thus, it appears that
UL36.512-767GFP competes with UL37GFP for binding to UL37HA. It may be possible
that binding of UL36 to UL37 alters the conformation of UL37, resulting in steric hindrance
that prevents the self-association of UL37. The role that self-association of UL37 may play
during infection is unclear. When UL37HA and UL37GFP are cotransfected into cells that
are subsequently infected with HSV-1, the self-association of UL37HA and UL37GFP is
readily detected in coimmunoprecipitation assays (data not shown). Although UL37 is
overexpressed through transient transfection in this experimental design, it appears that
UL37 does self-associate within the infected cell. Fuchs and colleagues reported that
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deletion of the domain of UL36 necessary for binding UL37 does not abrogate PRV virus
production, but reduces viral titers by 50-fold and produces capsids within the cytoplasm in
large ordered structures (Fuchs et al., 2004). Therefore, it appears that in PRV, UL36 is not
required to interact with UL37 in order to execute its essential function. UL37 plays a
critical role for assembly of HSV-1, but is not strictly essential for PRV replication. The
function and/or necessity of the UL36–UL37 interaction may differ among HSV-1 and PRV.
It is not yet understood if UL37 is dependent on the UL36–UL37 interaction to perform its
essential function during HSV-1 infection. Similarly, it is unknown if the self-interaction of
UL37 plays a vital role in virus replication. Exactly how the competition between UL36 and
UL37 to bind UL37 may impact virus assembly is unclear.
The amount of HSV-1 UL37 packaged into virions is tightly controlled (McLauchlan,
1997). Furthermore, relatively few copies of HSV-1 UL36 are packaged into virions; an
estimated 100–150 copies per virion (Heine et al., 1974). Based upon the incorporation of
UL36 and UL37, it is possible that the protein levels of UL37 and UL36 within the infected
cell may also be tightly controlled. Protein levels of the UL36 homologue of human
cytomegalovirus have been reported to be dependent on the presence of the UL37
homologue (Bechtel & Shenk, 2002). Therefore, protein levels of UL36 and UL37 within
the infected cell may also regulate the competition between UL36 and UL37 for binding
with other molecules of UL37. One may speculate that the self-association of UL37 and the
interaction of UL37 with UL36 may play roles at different sites of the infected cell.
Although UL37 and UL36 are binding partners, it is likely that they are not always in
abundance at the exact same locations within the cell, thus allowing UL37 to self associate
in some locations and bind UL36 in others.
In an effort to identify regions of UL37 that perform necessary functions for assembly of
infectious particles, plasmids encoding regions of UL37 were transfected into cells that were
subsequently infected with the UL37 deletion virus, KΔUL37. Cells and media were
harvested and analyzed by plaque assays to identify the regions of UL37 that rescue the
replication defective virus. Surprisingly, the only region of UL37 that provided partial
complementation was the region encoding amino acids 568–1123. The domain involved in
UL36 binding and a self-association domain are located within this region. However, other
truncation mutants that are capable of UL36 binding, such as UL37.301-1123HA and
UL37.1-809HA were not able to rescue the mutant virus. Similarly, other UL37 truncation
mutants capable of self-association were not able to complement KΔUL37. It is difficult to
interpret what these results teach us about the essential function of UL37. It is possible that
UL37 mutant proteins may perform a dominant-negative function within the infected cell,
interacting with binding partners, but in a manner that disrupts virus assembly. Similarly, it
is also unclear if the failure of UL37 mutant proteins to rescue KΔUL37 may be attributed
to aberrant conformational structures that inhibit UL37 from performing essential
function(s) during infection. Several truncation mutants that are capable of binding UL36
and/or self-association in transfection-immunoprecipitation assays also did not rescue the
UL37 deletion virus. These results may also suggest that UL37 performs a function, in
addition to self-association and UL36 binding, that maps to residues 568–1123 and is
necessary for productive infection. The specific essential function(s) that UL37 plays during
virus assembly remains to be determined.
UL37.568-1123HA was the only truncation mutant analyzed that was able to partially
complement KΔUL37. To determine if this complementation might possibly be attributable
to the ability of UL37.568-1123HA to interact with UL36, it was necessary to demonstrate
the interaction of UL37.568-1123HA with full-length virus-expressed UL36.
Coimmunoprecipitation from transfected-infected cytoplamsic lysates lacking capsid
structures verified that UL37.568-1123HA is capable of interacting with virus-expressed
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full-length UL36 (Fig. 10), in addition to binding UL36.512-767GFP in transfected cells
(Fig. 1). Based on these results, it seems likely that UL37.568-1123HA also interacts with
virus-expressed UL36 in KΔUL37-infected cells. The interaction of UL37.568-1123HA and
virus-expressed UL36 may or may not contribute to the partial complementation of
KΔUL37 seen in figure 9.
It is also intriguing if self-association of UL37 plays an essential role in infection. It is clear
that UL37 and UL37 truncation mutants self-associate in transfected cells (Figs. 5, 6 and 7),
but the occurrence of the interaction is more difficult to interpret in infected cells. UL37HA
and UL37GFP readily coimmunoprecipitate from cotransfected cells subsequently infected
with HSV-1 K23Z, KΔUL37 or KΔUL36, a virus that fails to express most of the UL36
open reading frame (Desai, 2000) (data not shown). However, in this experimental scenario,
expression of plasmid-encoded UL37 is presumably altered in kinetics and increased in
amount as compared to virus-expressed UL37. Attempts were also made to
coimmunoprecipitate UL37.568-1123HA from K23Z-infected cells. In these analyses
UL37.568-1123HA showed minimal levels of binding to virus-expressed UL37 (data not
shown). However, virus-expressed UL37 and UL37HA differ in only 9 amino acids in size
and migrate at the same location on an SDS-PAGE gel. Therefore, the low level of binding
of UL37.568-1123HA cannot be directly compared with a level of coimmunoprecipitation
of transiently expressed full-length UL37HA in the virus-infected cells and thus, lacks clear
interpretation. In spite of several attempts, it remains to be determined if self-association of




Vero cells (ATCC CCL-81) were grown in Dulbecco’s modified Eagles Medium (DMEM)
supplemented with 5% fetal bovine serum (FBS), 2.25% sodium bicarbonate, 25mM
HEPES buffer, glutamine (300 µg/ml), penicillin (100 µg/ml) and streptomycin (131 µg/ml).
Infected cells were grown in DMEM with a reduced FBS concentration of 2%. HSV-1 KOS
strain was used as the wild type strain (SMITH, 1964). A UL37 deletion virus, KΔUL37,
and Vero cell line that stably expresses UL37 (BD45), were kind gifts from Prashant Desai
(Desai et al., 2001). BD45 cells were grown in DMEM with 5% FBS. K23Z HSV-1 was
also a kind gift from Prashant Desai (Desai et al., 1993).
Antibodies
Rabbit anti-HA antisera used for Western blotting and immunoprecipitation was purchased
from Sigma. Goat anti-HA antibody used for Western blotting was purchased from Santa
Cruz. Rabbit polyclonal anti-GFP antibody used for Western blotting was kindly provided
by John Wills, Penn State College of Medicine. Goat polyclonal anti-GFP antibody used for
Western blotting and immunoprecipitation was purchased from Rockland. Rabbit TrueBlot
HRP-conjugated anti-rabbit antibody was purchased from eBioscience. Rabbit polyclonal
anti-UL36 antibody was described previously (McNabb & Courtney, 1992).
Cloning
The UL37 gene was amplified from the HSV-1 KOS genome by PCR amplification using
Platinum Pfx polymerase (Invitrogen). A forward primer containing a BglII site 50 bp
upstream of the start codon of UL37 and a reverse primer containing an EcoRI site in place
of the stop codon of UL37 were used for amplification. The DNA product was digested with
EcoRI and BglII and ligated into the vector pEGFP-n2 (Clontech) also digested with the
same restriction enzymes. Two separate clones produced from separate PCR reactions were
Bucks et al. Page 11













sequenced and compared. Amino acid sequences of the UL37 codons were identical and one
plasmid was selected and designated UL37GFP.
The UL37HA plasmid was generated by excising the UL37 fragment from the UL37GFP
plasmid, described above, using EcoRI and BglII. This fragment was ligated into a
hemagglutinin (HA) containing plasmid, UL46HA, (Murphy et al., 2008) that was digested
with the same restriction enzymes. The parental vector of the UL46HA plasmid was the
pEGFP-n2 GFP vector that was previously modified to replace the GFP sequence with the
HA sequence (Loomis et al., 2006). The newly constructed plasmid, UL37HA, was
sequenced to ensure that UL37 was in frame with HA.
UL37 C-terminal GFP and HA truncation mutants were constructed by using the forward
primer used to make the UL37GFP plasmid and a reverse primer that contains an EcoRI site
immediately downstream of the truncation site. The PCR products were digested with BglII
and EcoRI and ligated into UL37GFP or UL46HA plasmids digested with the same
restriction enzymes. The resulting inserts were sequenced to ensure that they contained the
specified UL37 truncation sequences and were in frame with GFP or HA.
To construct the UL37HA N-terminal truncation mutants, the UL37HA plasmid was
modified to contain a HindIII restriction enzyme site immediately upstream of the start
codon of UL37. The QuickChange II XL Site-Directed Mutagenesis kit (Stratagene) was
used according to the manufacturer’s instructions to insert the HindIII site into the UL37HA
plasmid to generate the UL37HA-HindIII plasmid. UL37HA-HindIII plasmid contains 50 bp
of genomic sequence upstream of the UL37 start site, followed by a HindIII restriction site
immediately upstream of the first UL37 amino acid. UL37HA N-terminal truncation
mutants were amplified with forward primers containing a HindIII site and start codon
immediately upstream of the first codon of the specified truncation mutant. The reverse
primer used was the same reverse primer utilized to create the UL37HA plasmid and
contains an EcoRI restriction site. The above mentioned primers were used to amplify the
mutant UL37 inserts, which were then digested with HindIII and EcoRI and ligated into
UL37HA-HindIII plasmid previously digested with the same enzymes. The resulting N-
terminal UL37HA truncation mutants contained 50 bp of genomic upstream sequence, a
start codon, the truncated amino acid sequence and the HA tag. The UL37HA truncation
mutant plasmids were sequenced to verify the correct mutant UL37 coding regions. The
UL37GFP N-terminal truncation mutants were constructed by excising the UL37 mutant
fragments from the respective UL37HA plasmids using EcoRI and BglII and then ligating
the sequences into UL37GFP plasmid previously digested with the same enzymes.
Plasmids containing internal sequences of UL37 were made by amplifying the UL37
sequence with forward primers containing a HindIII site and start codon immediately before
the first UL37 codon of the mutant protein. Reverse primers contained an EcoRI site that
was immediately downstream of the last UL37 codon of the mutant protein. The inserts were
amplified by PCR, digested with HindIII and EcoRI and ligated into UL37.568-1123HA
plasmid previously digested with the same enzymes. The resulting plasmids contain 50 bp of
HSV-1 sequence upstream of the UL37 start codon, followed by a methionine start codon,
the internal UL37 sequence and the HA tag.
UL37Δ568-809.HA and UL37Δ568-809. GFP were generated using the QuickChange II
XL Site-Directed Mutagenesis kit (Stratagene) according to the manufacturer’s instructions.
PCR primers complementary to nucleotides encoding amino acids 563–567 and 810–814
were used to generate a PCR product from UL37HA and UL37GFP templates, looping out
codons 568–809 of UL37. Clones were screened by restriction enzyme digestion and
sequenced to verify the removal of codons 568–809.
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The UL36.512-767 gene fragment was amplified from HSV-1 KOS genomic DNA by PCR
amplification using Platinum Pfx polymerase (Invitrogen). A forward primer containing a
BglII site and an ATG start sequence immediately before codon 512 and a reverse primer
containing a MfeI site directly after codon 767 was used to amplify codons 512–767 of
UL36. The amplified DNA was digested with BglII and MfeI and ligated into the vector
pEGFP-n2 (Clontech) digested with BglII and EcoRI. The resulting plasmid,
UL36.512-767GFP, was sequenced to verify the correct amino acid sequence and that the
gene fragment was in frame with the downstream GFP.
Coimmunoprecipitation
Vero cells grown to approximately 90–95% confluency in 60 mm or 100 mm plates were
transfected with Lipofectamine 2000 (Invitrogen) according to the manufacturer’s
instructions. Approximately 20–24 h post-transfection cells were washed twice with
phosphate-buffered saline (PBS) and harvested by scraping. Cells were pelleted by
centrifugation at 1000 × g for 10 min at 4°C and resuspended in 1% NP40 lysis buffer (50
mM Tris-HCl pH 7.4, 150 mM NaCl, 2mM MgCl, 1% NP40, 0.1% Sigma protease inhibitor
cocktail). Cells were then incubated on ice for 30 min and nuclei were pelleted by
centrifugation at 1000 × g for 10 min at 4°C. The cytoplasmic fraction was clarified further
by centrifugation at 14,000 rpm for 5 min at 4°C in a microfuge. The cytoplasmic lysate was
precleared for approximately 1 h with protein G-agarose beads (Roche) that were washed
three times in lysis buffer. Protein G-agarose beads were pelleted at 14,000 rpm for 5 min at
4°C in a microfuge. Immunoprecipitation antibody was added to the precleared samples and
rocked at 4°C for a minimum of 1 h. Protein G-agarose beads were added to the samples and
rocked overnight at 4°C. Immune complexes were washed three times in lysis buffer. 2×
sample buffer (3.6% SDS, 18% βME, 114 mM Tris pH 6.8, 0.05% bromophenol blue and
18% glycerol) was added to the beads and the immunoprecipitated material was separated
by SDS-PAGE, transferred to nitrocellulose membranes and analyzed by Western blotting
using the antibodies mentioned above, ECL reagents, and autoradiography using Kodak
BioMax XAR film. For sequential probing of the same nitrocellulose membrane, blots were
submerged in stripping buffer (60 mM Tris-HCl pH 8.0, 2% SDS and 0.75% βME) at 56°C
for approximately 35 minutes to remove bound antibodies. Although results and
interpretations are consistent between repetitions of experiments, quantification of
immunoprecipitated material was attempted but unsuccessful. Comparison of relative levels
of binding requires densitometric quantification of four separate Western blots for each
repetition of an experiment. In some of these experiments the density of the protein bands
was not within linear range for all four separate Western blots of an experiment. Therefore
quantification and normalization could not be accurately performed.
Transfection-Infection Assay
Vero cells grown in 100 mm plates were transfected with Lipofectamine 2000 (Invitrogen)
according to the manufacturer’s instructions. Approximately 24 h post-transfection, cells
were infected with HSV-1 K23Z (Desai et al., 1993) with an MOI of 10. Approximately 24
h after infection, cells were harvested by scraping, washed twice with phosphate-buffered
saline (PBS) and immunoprecipitation, SDS-PAGE and Western blotting were performed as
described above.
Trans-Complementation Assay
Vero cells grown in 60 mm plates to approximately 90–95% confluency were transfected
with the indicated plasmids using Lipofectamine 2000 (Invitrogen) according to the
manufacturer’s instructions. Approximately 24 h after transfection cells were infected with
KΔUL37 HSV-1 at an MOI of 1. Infected cells were grown in 3.5 ml of DMEM containing
2% FBS. At 48 h after infection, media and cells were collected. Cells were lysed by three
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cycles of freeze thaw and cell debris was pelleted by centrifugation at 750 × g for 10 min at
4°C. Cellular debris was analyzed by SDS-PAGE and Western blotting to verify expression
of the transfected plasmids. Media supernatant was stored at −80°C before analysis by
plaque assay. The amount of infectious virions in the media supernatant was determined by
plaque titration assays on BD45 cells. Titrations were performed in duplicate. Each plasmid
was analyzed for trans-complementation a minimum of three times and results of the
independent titrations were averaged and presented as percent PFU/ml as compared to full
length UL37HA.
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Figure 1. Coimmunoprecipitation of UL36.512-767GFP with N-Terminal and C-Terminal
UL37HA Truncation Mutants
(A) A schematic representation of HA tagged full length, N-terminal and C-terminal UL37
truncation mutants. Additionally, a tabular summary of results indicate the UL37HA
truncation mutants that bind (+) or do not bind (−) UL36.512-767GFP (UL36GFP) in
coimmunoprecipitation assays. Molecular weight values were predicted by Statistical
Analysis of Protein Sequence accessed through SDSC Biology Workbench. (B) Expression
of UL37HA truncation mutants and UL36.512-767GFP. Vero cells were cotransfected with
UL36.512-767GFP and the indicated UL37HA constructs, harvested at 24 h post-
transfection and lysed in NP40 lysis buffer. Each cytoplasmic lysate was analyzed by
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Western blotting using rabbit HA antibody (αHA, top panel) or goat GFP antibody (αGFP,
bottom panel). (C) Coimmunoprecipitation of UL36.512-767GFP with UL37 HA constructs.
Cotransfected cytoplasmic lysates were incubated with an anti-HA rabbit antibody and then
bound to protein-G agarose beads. Immunoprecipitated material was separated on an SDS-
PAGE gel and transferred to nitrocellulose. Proteins were detected by Western blotting
using a goat anti-HA antibody (αHA, top panel) or goat anti-GFP antibody (αGFP, bottom
panel).
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Figure 2. Analysis of the Ability of UL36.512-767GFP to Interact with a UL37HA Mutant
Lacking Residues 568–809
(A) A schematic representation of the UL37HA mutants. UL37HA mutants were
cotransfected into Vero cells with UL36.512-767GFP. A tabular summary of results indicate
the UL37HA truncation mutants that bind (+) or do not bind (−) UL36.512-767GFP
(UL36GFP) in coimmunoprecipitation assays. Molecular weight values were predicted by
Statistical Analysis of Protein Sequence accessed through SDSC Biology Workbench.
Immunoprecipitation and Western blot analysis was performed as described in the legend to
Fig. 1. (B) Expression of the GFP and HA fusion proteins in whole cell lysates was analyzed
by Western blotting with rabbit anti-HA (αHA, top panel) and rabbit anti-GFP (αGFP,
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bottom panel) antibodies. (C) The ability of the UL37HA mutants to bind
UL36.512-767GFP was analyzed by Western blotting membranes of the
coimmunoprecipitated material with goat anti-GFP antibody (αGFP, bottom panel). Rabbit
anti-HA antibody and rabbit TrueBlot HRP-conjugated anti-rabbit secondary antibody was
used to verify immunoprecipitated UL37HA constructs (αHA, top panel).
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Figure 3. Coimmunoprecipitation of UL36.512-767GFP with Internal UL37HA Mutants
(A) A schematic representation of the internal UL37HA truncation mutants. Plasmids
encoding internal domains of UL37HA were cotransfected into Vero cells with
UL36.512-767GFP. Immunoprecipitation and Western blot analysis was performed as
described in the legend to Fig. 1. A tabular summary of results indicate the UL37HA
truncation mutants that bind (+) or do not bind (−) UL36.512-767GFP (UL36GFP) in
coimmunoprecipitation assays. Molecular weight values were predicted by Statistical
Analysis of Protein Sequence accessed through SDSC Biology Workbench. (B) Expression
of the GFP and HA fusion proteins in whole cell lysates was analyzed by Western blotting
with rabbit anti-HA (αHA, top panel) and rabbit anti-GFP (αGFP, bottom panel) antibodies.
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(C) The ability of the internal UL37HA mutants to bind UL36.512-767GFP was analyzed by
Western blotting membranes of the coimmunoprecipitated material with goat anti-GFP
antibody (αGFP, bottom panel). Rabbit anti-HA antibody and rabbit TrueBlot HRP-
conjugated anti-rabbit secondary antibody was used to verify immunoprecipitated UL37HA
constructs (αHA, top panel).
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Figure 4. Coimmunoprecipitation of UL36.512-767GFP with Additional Internal UL37HA
Mutants
(A) A schematic representation of the internal UL37 truncation mutants. Plasmids encoding
internal domains of UL37HA were cotransfected into Vero cells with UL36.512-767GFP.
Immunoprecipitation and Western blot analysis was performed as described in the legend to
Fig. 1. A tabular summary of results indicate the UL37HA truncation mutants that bind (+),
do not bind (−) or reproducibly bind UL36.512-767GFP (UL36GFP) weakly (wk) in
coimmunoprecipitation assays. Molecular weight values were predicted by Statistical
Analysis of Protein Sequence accessed through SDSC Biology Workbench. (B) Expression
of the GFP and HA fusion proteins in whole cell lysates was analyzed by Western blotting
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using rabbit anti-HA (αHA, top panel) and rabbit anti-GFP (αGFP, bottom panel)
antibodies. (C) The ability of the internal UL37HA mutants to bind UL36.512-767GFP was
analyzed by Western blotting the immunoprecipitated material with goat anti-GFP antibody.
Rabbit anti-HA antibody and rabbit TrueBlot HRP-conjugated anti-rabbit secondary
antibody was used to verify immunoprecipitated UL37HA constructs.
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Figure 5. Coimmunoprecipitation of UL37HA with GFP tagged N-Terminal and C-Terminal
UL37 Truncation Mutants
(A) A schematic representation of full length, N-terminal and C-terminal UL37 truncation
mutants fused to GFP. A tabular summary of results indicate the UL37GFP truncation
mutants that bind (+) or do not bind (−) UL37HA in coimmunoprecipitation assays.
Molecular weight values were predicted by Statistical Analysis of Protein Sequence
accessed through SDSC Biology Workbench. (B) Expression of the UL37 constructs. Vero
cells cotransfected with the indicated constructs were harvested approximately 24 h post-
transfection and lysed in NP40 lysis buffer. A fraction of the cytoplasmic lysates was
analyzed using rabbit antibodies to GFP (αGFP, top panel) and HA (αHA, bottom panel).
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(C) Coimmunopreciptitation of UL37GFP constructs with UL37HA. Transfected cell lysates
were incubated with goat anti-GFP antibody and then bound to protein-G agarose beads.
Immunoprecipitated material was analyzed on a SDS-PAGE gel and transferred to
nitrocellulose. Proteins were detected by Western blotting using rabbit antibodies to GFP
(αGFP, top panel) and HA (αHA, bottom panel).
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Figure 6. Interactions of Amino- and Carboxy-Terminal UL37 Self-Association Domains
Analyzed by Coimmunoprecipitation-Western Blot Analysis
(A) A schematic representation of the UL37 N-terminal and C-terminal HA and GFP fusion
constructs used in the coimmunoprecipitation assays. A tabular summary of results indicate
the UL37GFP truncation mutants that bind (+) or do not bind (−) UL37HA truncation
mutants in coimmunoprecipitation assays. Possible combinations of coimmunoprecipitations
that were not tested are indicated by “nt.” (B, D, F) Expression of cotransfected UL37HA
and UL37 GFP mutants. Vero cells were cotransfected with the indicated plasmids,
harvested at approximately 24 h post-transfection and lysed in NP40 lysis buffer. A portion
of each cytoplasmic lysate was analyzed for protein expression using rabbit antibodies to
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HA (αHA, top panels) and GFP (αGFP, bottom panels). (C, E, G) Coimmunoprecipitation
of UL37 HA-tagged and UL37 GFP-tagged mutant proteins. Coimmunoprecipitations were
performed and analyzed as described in the legend to Fig. 5. Western blotting with rabbit
anti-HA (αHA, top panels) and anti-GFP (αGFP, bottom panels) antibodies was used to
determine if the UL37HA mutants coimmunoprecipitated with the GFP fusion constructs.
Bucks et al. Page 29













Figure 7. Coimmunoprecipitation of UL37HA and UL37.Δ568-809GFP
(A) A schematic representation of the UL37GFP constructs cotransfected with full length
UL37HA construct. A tabular summary of results indicate the UL37GFP truncation mutants
that bind (+) or do not bind (−) UL37HA in coimmunoprecipitation assays. Molecular
weight values were predicted by Statistical Analysis of Protein Sequence accessed through
SDSC Biology Workbench. (B) Expression of UL37HA. Vero cells cotransfected with the
indicated constructs were harvested at approximately 24 h post-transfection and lysed in
NP40 lysis buffer. A portion of the cytoplasmic lysates was analyzed for protein expression
using a rabbit anti-HA antibody. (C) Coimmunoprecipitation of UL37.Δ568-809GFP with
UL37HA. Coimmunoprecipitations were performed and analyzed as described in the legend
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to Fig. 5. Coimmunoprecipitated proteins were detected by Western blotting with rabbit
anti-GFP (αGFP, bottom panel) and rabbit anti-HA (αHA, top panel) antibodies.
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Figure 8. Coimmunoprecipitation Analysis of UL37HA when Coexpressed with UL37GFP and
UL36.512-767GFP
(A) Vero cells were cotransfected with the indicated amounts UL36.512-767GFP, UL37HA
and UL37GFP plasmids. At approximately 24 h post-transfection, cells were harvested,
lysed in NP40 lysis buffer and a portion of the cytoplasmic lysate was analyzed for protein
expression by Western blotting using goat anti-GFP antibodies. Arrows indicate the
positions of UL37GFP and UL36.512-767GFP. (B) Coimmunoprecipitation of UL37GFP
and/or UL36.512-767GFP with UL37HA. Coimmunoprecipitation with anti-HA antisera
was performed as described in the legend to Fig. 1. Immunoprecipitated material was
analyzed by Western blot analysis using a goat anti-HA antibody (αHA, top panel) and goat
anti-GFP antibody (αGFP, bottom panel). Arrows indicate the positions of UL37GFP and
UL36.512-767GFP in the bottom panel.
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Figure 9. Transfection-Infection Experiments to Assess the Ability of UL37HA Mutants to
Complement the KΔUL37 Virus
Cells were transfected with the indicated UL37HA constructs, and approximately 24 h later
infected with KΔUL37 virus with an MOI of 1. Approximately 48 h after infection, cells
and media were harvested and lysed by three cycles of freeze/thaw. Cellular debris was
pelleted and the supernatant was titered on UL37 expressing cells (BD45) to quantitate the
amount of infectious virus released. Titrations for each UL37 construct represent the average
of a minimum of three independent experiments, error bars represent the calculated standard
error of measurement, (SEM). For each independent experiment, the titers were compared
by determining the percent of virus released as compared to UL37HA (%PFU/ml for the
UL37HA sample equals 100% for each experiment).
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Figure 10. Coimmunoprecipitation of virus-expressed full-length UL36 and UL37.568-1123HA
Vero cells were transfected with the indicated UL37HA plasmids and 24 h later infected
with K23Z HSV-1 at an MOI of 10. Approximately 24 h post-infection cells were harvested
and immunoprecipitation was performed as described in the legend to Fig. 1. (A) Each
cytoplasmic lysate was analyzed by Western blotting using rabbit HA antibody (αHA, top
panel) or rabbit UL36 antibody (αUL36, bottom panel). (B) The ability of K23Z-expressed
full-length UL36 to bind UL37HA constructs was analyzed by Western blotting the
membranes of the coimmunoprecipitated material with rabbit anti-UL36 antibody (αUL36,
bottom panel) and rabbit TrueBlot HRP-conjugated anti-rabbit secondary antibody. Western
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blotting with rabbit anti-HA antibody and rabbit TrueBlot HRP-conjugated anti-rabbit
secondary antibody verified imunoprecipitated UL37HA complexes.
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Figure 11. Schematic Representation of Identified Domains and Epitopes of UL37
Amino acids 1–300 function as a UL37 multimerization domain (N UL37-UL37 dom), an
alanine-rich region encompasses residues 44–80 (ARR), a leucine zipper motif spans
residues 203–224 (L Zip) and a leucine-rich region at amino acids 263–272 functions as a
nuclear export signal (LRR/NES) (Watanabe et al., 2000). The C-terminal half of UL37,
amino acids 568–1123, functions as a UL37 self-association domain (C UL37-UL37 dom),
is involved in binding UL36 (UL36–UL37 dom) and this region partially complements the
KΔUL37 virus in transfected cells (Resc. KΔUL37). UL37 activates NFκ-B through
binding TRAF6 at residues 1099–1104 (UL37-TRAF6 dom) (Liu et al., 2008). Throughout
UL37 are 17 dileucine motifs (LL or LI) and 3 tyrosine-based motifs (YXXΦ, where Φ
represents a large hydrophobic residue) which may facilitate interactions with clathrin
adaptor proteins to promote vesicular trafficking (Boll et al., 1996, Kirchhausen et al., 1997;
Kirchhausen, 1999; Wan et al., 1998). Conserved residues span the length of UL37, with the
exception of approximately 100 unconserved amino acids at the amino and carboxy-termini.
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